The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancer
Identifieur interne : 009A89 ( Main/Exploration ); précédent : 009A88; suivant : 009A90The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancer
Auteurs : Nizar Habal [États-Unis] ; Armando E. Giuliano [États-Unis] ; Donald L. Morton [États-Unis]Source :
- Seminars in Oncology [ 0093-7754 ] ; 2001.
Abstract
Sentinel lymphadenectomy (SLND) is fast becoming the procedure of choice for staging primary breast carcinoma and melanoma. This simpler and less morbid alternative to standard lymph node dissection can increase the rate of detecting nodal disease. Because the tumor status of the regional lymph nodes remains a significant prognostic tool in both diseases, clinicians may use SLND to facilitate selection of patients for adjuvant chemotherapy. Although SLND has been validated by institutions worldwide, it continues to evolve. The following review will examine current data and controversies surrounding this emerging technology.
Url:
DOI: 10.1016/S0093-7754(01)90044-2
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003942
- to stream Istex, to step Curation: 003942
- to stream Istex, to step Checkpoint: 002779
- to stream Main, to step Merge: 009F38
- to stream Main, to step Curation: 009A89
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancer</title><author><name sortKey="Habal, Nizar" sort="Habal, Nizar" uniqKey="Habal N" first="Nizar" last="Habal">Nizar Habal</name></author><author><name sortKey="Giuliano, Armando E" sort="Giuliano, Armando E" uniqKey="Giuliano A" first="Armando E" last="Giuliano">Armando E. Giuliano</name></author><author><name sortKey="Morton, Donald L" sort="Morton, Donald L" uniqKey="Morton D" first="Donald L" last="Morton">Donald L. Morton</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:7A7AE56241211D63D73EFA367CB8AD1BF783D287</idno><date when="2001" year="2001">2001</date><idno type="doi">10.1016/S0093-7754(01)90044-2</idno><idno type="url">https://api.istex.fr/document/7A7AE56241211D63D73EFA367CB8AD1BF783D287/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003942</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">003942</idno><idno type="wicri:Area/Istex/Curation">003942</idno><idno type="wicri:Area/Istex/Checkpoint">002779</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002779</idno><idno type="wicri:doubleKey">0093-7754:2001:Habal N:the:use:of</idno><idno type="wicri:Area/Main/Merge">009F38</idno><idno type="wicri:Area/Main/Curation">009A89</idno><idno type="wicri:Area/Main/Exploration">009A89</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancer</title><author><name sortKey="Habal, Nizar" sort="Habal, Nizar" uniqKey="Habal N" first="Nizar" last="Habal">Nizar Habal</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Roy E. Coats Research Laboratories and the Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Giuliano, Armando E" sort="Giuliano, Armando E" uniqKey="Giuliano A" first="Armando E" last="Giuliano">Armando E. Giuliano</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Roy E. Coats Research Laboratories and the Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Morton, Donald L" sort="Morton, Donald L" uniqKey="Morton D" first="Donald L" last="Morton">Donald L. Morton</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Roy E. Coats Research Laboratories and the Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Seminars in Oncology</title><title level="j" type="abbrev">YSONC</title><idno type="ISSN">0093-7754</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2001">2001</date><biblScope unit="volume">28</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="41">41</biblScope><biblScope unit="page" to="52">52</biblScope></imprint><idno type="ISSN">0093-7754</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0093-7754</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Sentinel lymphadenectomy (SLND) is fast becoming the procedure of choice for staging primary breast carcinoma and melanoma. This simpler and less morbid alternative to standard lymph node dissection can increase the rate of detecting nodal disease. Because the tumor status of the regional lymph nodes remains a significant prognostic tool in both diseases, clinicians may use SLND to facilitate selection of patients for adjuvant chemotherapy. Although SLND has been validated by institutions worldwide, it continues to evolve. The following review will examine current data and controversies surrounding this emerging technology.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li></region></list><tree><country name="États-Unis"><region name="Californie"><name sortKey="Habal, Nizar" sort="Habal, Nizar" uniqKey="Habal N" first="Nizar" last="Habal">Nizar Habal</name></region><name sortKey="Giuliano, Armando E" sort="Giuliano, Armando E" uniqKey="Giuliano A" first="Armando E" last="Giuliano">Armando E. Giuliano</name><name sortKey="Morton, Donald L" sort="Morton, Donald L" uniqKey="Morton D" first="Donald L" last="Morton">Donald L. Morton</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009A89 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 009A89 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:7A7AE56241211D63D73EFA367CB8AD1BF783D287
|texte= The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancer
}}
| This area was generated with Dilib version V0.6.31. |  |